The squamous cell carcinoma antigen/SERPINB3 protects cervical cancer cells from chemoradiation by preventing lysoptosis
Songyan Wang(Beijing Normal University), Stephanie Markovina(Washington University in St. Louis)
Cited by 1
Related Papers
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|507
Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
|British Journal of Cancer|2017|73
SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation
|Communications Biology|2022|30
NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
|Journal of the National Comprehensive Cancer Network|2025|30